JPH0432060B2 - - Google Patents
Info
- Publication number
- JPH0432060B2 JPH0432060B2 JP4512785A JP4512785A JPH0432060B2 JP H0432060 B2 JPH0432060 B2 JP H0432060B2 JP 4512785 A JP4512785 A JP 4512785A JP 4512785 A JP4512785 A JP 4512785A JP H0432060 B2 JPH0432060 B2 JP H0432060B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl group
- lower alkyl
- reaction
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 63
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 229930192627 Naphthoquinone Natural products 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 150000002791 naphthoquinones Chemical class 0.000 claims description 7
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 5
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000002541 furyl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 93
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- 238000006243 chemical reaction Methods 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 35
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- -1 methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butyloxy Chemical group 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 239000013078 crystal Substances 0.000 description 25
- 239000002904 solvent Substances 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000007254 oxidation reaction Methods 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000012046 mixed solvent Substances 0.000 description 12
- 238000007796 conventional method Methods 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 150000004820 halides Chemical class 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000009835 boiling Methods 0.000 description 7
- 125000001624 naphthyl group Chemical group 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- FRASJONUBLZVQX-UHFFFAOYSA-N naphthoquinone group Chemical group C1(C=CC(C2=CC=CC=C12)=O)=O FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 238000010531 catalytic reduction reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000007818 Grignard reagent Substances 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000004795 grignard reagents Chemical class 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229910001923 silver oxide Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 150000004967 organic peroxy acids Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- ULQQGOGMQRGFFR-UHFFFAOYSA-N 2-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC=C1Cl ULQQGOGMQRGFFR-UHFFFAOYSA-N 0.000 description 1
- SMFSDQSZGCZDAI-UHFFFAOYSA-N 2-naphthalen-1-ylprop-2-enoic acid Chemical compound C1=CC=C2C(C(=C)C(=O)O)=CC=CC2=C1 SMFSDQSZGCZDAI-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 238000006680 Reformatsky reaction Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000005255 carburizing Methods 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004002 naphthaldehydes Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical class OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Description
産業上の利用分野
本発明はナフトキノン誘導体に関する。
従来の技術
本発明のナフトキノン誘導体は、文献未載の新
規化合物である。
発明が解決しようとする問題点
本発明は、後記するように医薬品として有用な
化合物を提供することを目的とする。
問題点を解決するための手段
本発明によれば、下記一般式(1)で表わされるナ
フトキノン誘導体が提供される。
〔式中R1は低級アルキル基を示す。R2は置換基
として水酸基を有することのある低級アルキル
基、低級アルコキシカルボニル低級アルキル基、
低級アルキルカルボニルオキシ低級アルキル基、
低級アルコキシカルボニルオキシ低級アルキル
基、カルボキシ低級アルキル基又はベンゾイルオ
キシ低級アルキル基を示す。R3はアルキル基、
ヒドロキシ低級アルキル基、置換基として低級ア
ルキル基、ハロゲン原子、低級アルコキシ基、カ
ルボキシ基又はカルボキシ低級アルキル基を有す
ることのあるフエニル基、フエニル環上に置換基
として低級アルコキシ基を有することのあるフエ
ニル低級アルキル基、低級アルコキシカルボニル
低級アルキル基又はフラニル低級アルキル基を示
す。nは0、1又は2を示す〕
本明細書において、低級アルキル基なる語は、
炭素数1〜6の直鎖状又は分枝鎖状アルキル基を
指称するものであり、その具体例としては、メチ
ル、エチル、プロピル、イソプロピル、ブチル、
イソブチル、sec−ブチル、tert−ブチル、ペン
チル、ヘキシル基等を例示できる。アルキル基な
る語には、上記低級アルキル基の他、例えばオク
チル、ノニル、デシル、ウンデシル、ドデシル、
テトラデシル、ヘキサデシル、オクタデシル、エ
イコシル基等が包含される。また低級アルコキシ
基なる語は、炭素数1〜6の直鎖状又は分枝鎖状
アルコキシ基を指称し、その例としては、メトキ
シ、エトキシ、プロポキシ、イソプロポキシ、ブ
トキシ、tert−ブチルオキシ、ペンチルオキシ、
ヘキシルオキシ基等を例示できる。ハロゲン原子
には塩素、弗素、沃素及び臭素原子が包含され
る。一般式(1)中、R2及びR3で定義される低級ア
ルコキシカルボニル低級アルキル基、低級アルキ
ルカルボニルオキシ低級アルキル基及び低級アル
コシキシカルボニルオキシ低級アルキル基は、い
ずれも上記低級アルキル基又は低級アルコキシ基
と上記低級アルキル基とを構成成分として含んで
いる。カルボキシ低級アルキル基、ベンゾイルオ
キシ低級アルキル基及びヒドロキシ低級アルキル
基は、カルボキシ基、ベンゾイルオキシ基又はヒ
ドロキシ基を置換基として有する上記低級アルキ
ル基である。フエニル環上に置換基として低級ア
ルコキシ基を有することのあるフエニル低級アル
キル基としては、例えばベンジル、フエネチル、
フエニルプロピル、フエニルブチル、フエニルペ
ンチル、フエニルヘキシル基等の無置換フエニル
低級アキル基及びメトキシベンジル、エトキシベ
ンジル、メトキシフエネチル、エトキシフエニル
ブチル基等の低級アルコキシ置換フエニル低級ア
ルキル基を例示できる。また置換基として低級ア
ルキル基、ハロゲン原子、低級アルコキシ基、カ
ルボキシ基又はカルボキシ低級アルキル基を有す
ることのあるフエニル基は、フエニル環上に上記
各置換基の複数個を有していてもよく、この場合
置換基は同種であつても異種であつてもよい。
本発明の上記一般式(1)で表わされる化合物及び
その塩は、プロスタグランジン生合成の遮断作用
や調節作用を有し動物、とりわけ哺乳動物に対し
て抗炎症、抗リウマチ、抗アレルギー、鎭痛、利
尿、血小板凝集阻止、血圧降下等の作用を示す。
従つてこれは抗炎症剤、抗リウマチ剤、抗アレル
ギー剤、鎭痛剤、利尿剤、抗血栓剤、降圧剤等の
医薬として有用である。
本発明のナフトキノン誘導体は、例えば、下記
各反応工程式−1に示す方法により製造すること
ができる。
〔式中、R1、R2、R3は前記に同じ。R2′は置換基
として水酸基を有することのある低級アルキル
基、低級アルコキシカルボニル低級アルキル基又
はカルボキシ低級アルキル基を示し、R2″は低級
アルキルカルボニルオキシ低級アルキル基、低級
アルコキシカルボニルオキシ低級アルキル基又は
ベンゾイルオキシ低級アルキル基を示す。mは1
を示す。〕
反応工程式−1において、化合物(2)とチオール
化合物(R3SH)との反応は、不活性溶媒中で行
なわれる。該溶媒としては例えばメタノール、エ
タノール等の低級アルコール類、N,N−ジメチ
ルホルムアミド(DMF)、テトラヒドロフラン
(THF)、ジオキサン、水等及びこれらの混合溶
媒を使用できる。反応は好ましくは、窒素、アル
ゴン等の不活性気流下、化合物(2)に対してチオー
ル化合物を、通常0.5〜2倍モル量、好ましくは
約1〜1.1倍モル量用い、約0℃〜溶媒の沸点程
度、好ましくは約20〜80℃にて、約1〜50時間を
要して行なわれる。上記反応により中間体として
一般式
〔式中R1、R2′及びR3は上記に同じ〕
で表わされる縮合体が得られる。該縮合体は次い
で反応系内に過剰量の塩化第二鉄の水溶液を添加
するか又は酸素(空気)を吹きこむことにより酸
化され、かくして化合物(1−a)を収得でき
る。
得られる化合物(1−a)は、これを酸化する
ことにより容易に化合物(1−c)のスルフイニ
ル体とすることができる。この酸化反応は、適当
な酸化剤、例えば過沃素酸ナトリウム、過沃素酸
カリウム等の過沃素酸塩や、過酢酸、m−クロロ
過安息香酸等の有機過酸や過酸化水素等を用いて
通常の方法に従つて実施できる。より詳しくは、
上記酸化反応は、例えばメタノール、エタノール
等の低級アルコール類、ジクロロメタン、クロロ
ホルム等のハロゲン化炭化水素類、アセトン、ジ
オキサン、酢酸等の有機溶媒又はこれらの含水溶
媒中で行なわれる。上記酸化剤は、例えば有機過
酸では化合物(1−a)に対して約1〜1.2倍モ
ル量用いられる。反応は約−20〜30℃の温度条件
下に、約10分〜60分を要して行なわれる。
また化合物(1−a)中、R2′が置換基として
水酸基を有する低級アルキル基である化合物は、
これに適当な酸ハライドを反応させることによ
り、該水酸基をアシル化させて化合物(1−b)
とすることができる。該アシル化反応は、通常の
方法に従い、非プロトン性溶媒中、好ましくはア
ルカリの存在下に行なわれる。非プロトン性溶媒
としては例えばジクロルメタン、クロロホルム等
のハロゲン化炭化水素類、THF、ジオキサン等
のエーテル類、ベンゼン、トルエン等の芳香族炭
化水素類、ジメチルスルホキシド(DMSO)等
を使用できる。アシル化剤として用いられる酸ハ
ライドとしては、例えばアセチルクロライド、ア
セチルブロマイド、プロピオニルクロライド等の
低級脂肪酸のハライド類、カルボメトキシクロラ
イド、カルボエトキシクロライド、カルボプロポ
キシクロライド等のカルボ低級アルコキシクロラ
イド、ベンゾイルクロライド等のベンゾイルハラ
イド等を例示することができる。アルカリとして
は、例えばピリジン、トリエチルアミン等の有機
アミン類や炭酸カリウム、炭酸ナトリウム等の無
機化合物を例示できる。化合物(1−a)に対す
る酸ハライド及びアルカリの使用量は、限定的で
はないが、通常夫々約1〜5倍モル量、好ましく
は約1〜1.5倍モル量とするのが適当である。上
記アシル化反応は、一般に約0〜60℃の温度条件
下に実施され、約0.5〜5時間で完結し、かくし
て化合物(1−b)を収得できる。
該化合物(1−b)の酸化反応は、上記した化
合物(1−a)の酸化反応と同様にして行なわ
れ、これにより化合物(1−c)を収得できる。
上記各反応により得られる目的物は慣用の分離
手段、例えば溶媒抽出、再結晶、カラムクロマト
グラフイー等により容易に単離精製することがで
きる。
上記反応工程式−1において出発原料として用
いられる化合物は、例えば下記各反応工程式に従
つて得られる。
〔各式中R1は上記に同じ。〕
上記反応工程式−2において出発原料とする化
合物(A)は、公知である〔J.Org.Chem.、44、2153
(1979)〕。
化合物(A)のブロム化は、例えばN,N−ジメチ
ルホルムアミド(DMF)等の極性溶媒中、N−
ブロムコハク酸イミド(NBS)等のブロム化剤
を用いて実施される。ブロム化剤は化合物(A)に対
して好ましくは当モル量使用され、反応は約0〜
80℃の温度条件下に良好に進行し、約2〜16時間
で完結する。
上記により得られる化合物(B)の低級アルコキシ
化は、ラオ(Durvasula V.Rao)らの報文
〔Synthesis、308(1983)〕に従い、メタノール、
エタノール等の低級アルコール類のナトリウム塩
を化合物(B)に対して1〜4倍当量用いて、DMF
及び低級アルコール類の混合溶媒中、約80〜120
℃で1〜4時間程度を要して実施される。その際
銅塩例えば塩化第2銅、沃化第1銅等を化合物(B)
に対して約1/2〜2倍モル量用いれば反応はより
好適に進行する。かくして化合物(C)を収得する。
〔式中R1は上記に同じ。R4は低級アルキル基又
はベンジルオキシ低級アルキル基、R4′は置換基
として水酸基を有することのある低級アルキル
基、R4″は置換基として水酸基を有することのあ
る低級アルキル基又はカルボキシ低級アルキル基
を夫々示す。〕
上記の示す化合物(C)のグリニヤール反応は、通
常の方法に従つて実施できる。即ちグリニヤール
試薬を用い適当な溶媒中、約−20〜60℃、好まし
くは約0〜25℃の温度条件下に行なわれる。グリ
ニヤール試薬は常法に従つて、例えばハロゲン化
アルキル、ハロゲン化フエニル低級アルキル又は
ハロゲン化低級アルケニルとこれらハロゲン化物
1モルに対し約1.1〜1.2倍モル量のマグネシウム
とから容易に調製できる。溶媒としては通常のエ
ーテルやTHF等を用い得る。グリニヤール試薬
の使用量は、通常化合物(C)に対して等モル〜5倍
モル量、好ましくは化合物(C)の溶媒液が本来呈し
ている黄色が消失する量、通常約等モル〜4倍モ
ル量とするのが望ましい。かくして化合物(C−
1)を得る。
化合物(C−1)の脱水反応は、通常有機溶媒
中、酸触媒の存在下に行なわれる。溶媒として
は、例えばベンゼン、エーテル、クロロホルム、
ジクロルメタン等を使用できる。酸触媒として
は、例えば塩化水素ガス、p−トルエンスルホン
酸等を使用できる。反応は上記酸の触媒量を用い
て、約0℃〜溶媒の沸点温度範囲にて良好に進行
する。
上記脱水反応に引き続く、接触還元反応は、常
法に従い、例えば5〜10%パラジウムカーボン、
酸化白金(PtO2)、ラネーニツケル等を触媒とし
て用いて、アルコール、酢酸エチル、DMF、水、
エーテル等の溶媒中、常圧〜3気圧程度の水素圧
下に行なわれる。かくして原料化合物の脱ベンジ
ン化及び二重結合の還元が同時に行なわれ、化合
物(C−2)を収得できる。
化合物(C−2)の酸化反応は、目的とする化合
物(C−3)の有するR4″基の種類に応じて、例
えば次の二種の方法により行なわれる。即ち
R4″が置換基として水酸基を有することのある低
級アルキル基である化合物を製造する場合、上記
酸化反応は好ましくはセリツクアンモニウムニト
ラート〔(NH4)2Cl(NO3)6、以下「CAN」とい
う〕等の四価セリウム塩を用いる方法又は希硝酸
中、酸化銀(AgO)を用いる方法により行なわ
れる。上記CANを用いる方法は、例えばジオキ
サン、アセトニトリル、THF、ジクロルメタン、
クロロホルム、エーテル等の溶媒中、化合物(C
−2)に対して当モル〜5倍モル量、好ましくは
2〜2.5倍モル量のCANを用い、約−20〜60℃、
好ましくは約0〜30℃下に実施される。希硝酸中
AgOを用いる方法は、例えばアセトン、ジオキ
サン、THF、エーテル等の溶媒中、化合物(C
−2)に対して等モル〜20倍モル量、好ましくは
約3〜10倍モル量のAgO及び約6N前後の硝酸を
用い、0〜溶媒の沸点、好ましくは0〜60℃の温
度下に実施される。またR4″基がカルボキシ低級
アルキル基である化合物を製造する場合、上記酸
化反応は、R4′が水酸基を有する低級アルキル基
である化合物(C−2)を、ジヨーンズ
(Jones)試薬を用いる方法〔Reagents for
Orgnic Synthesis、Vol1、142、Wiley、New
York、1967〕に従わせることにより行なわれる。
即ち該酸化反応は、例えばアセトン、ジオキサ
ン、エーテル等、好ましくはアセトンを溶媒とし
て約0〜30℃の温度条件下に実施される。用いら
れるジヨーンズ試薬量は、化合物(C−2)に対
して、クロ酸量として当モル〜20倍モル量、好ま
しくは2〜8倍モル量とするのが好適である。該
ジヨーンズ酸化反応により、原料化合物(C−
2)の有する水酸基がカルボキシル基に変換され
ると同時にナフタレン環の酸化によつてナフトキ
ノン環が形成され、所望の化合物(C−3)が収
得される。
反応工程式−1における出発原料(2)の内、
R2′がメチル基又はヒドロキシメチル基であるも
のは、下記反応工程式−4に従う化合物(C)の還元
反応及びこれに引き続く生成化合物(D)の酸化反応
によつて、製造できる。
〔式中R1は前記に同じ。R2〓はメチル基又はヒ
ドロキシメチ基を示す。〕
上記において、化合物(C)の還元反応は、公知の
方法に従い、NaBH4、LiAlH4等のハイドライド
を用いる方法又は接触還元によることができる。
ハイドライド用いる還元反応によれば、R2〓が
ヒドロキシメチル基である化合物(D)を収得でき
る。接触還元は、好ましくは過塩素酸の少量(触
媒量)を用いて、常法に従い、例えば5〜10%パ
ラジウムカーボン、PtO2、ラネーニツケル等の
触媒の存在下、アルコール、酢酸エチル、DMF、
水、エーテル等の溶媒中、常圧〜10気圧程度の水
素圧下に実施され、これによりR2〓がメチル基
である化合物(D)を収得できる。
かくして得られる化合物(D)の酸化反応は、前述
したCANを用いる酸化反応と同様にして行なわ
れ、これにより化合物(E)を製造できる。
反応工程式−3に示す化合物(C−3)の内、
特にR4″がカルボキシメチル基であるものは、次
の反応工程式−5に示す方法によつても得られ
る。
〔各式中R1は前記に同じ。R5は低級アルキル基
を示す。〕
上記方法によれば化合物(C)の増炭反応を、レホ
ルマトスキイ反応に従い実施することにより、化
合物(F)を収得できる。該反応はベンゼン、トルエ
ン、キシレン等の溶媒中、亜鉛等の存在下に化合
物(C)にα−ハロ酢酸エステルを縮合させることに
より行なわれる。α−ハロ酢酸エステルとして
は、ブロム酢酸低級アルキルエステルが好ましく
用いられる。その使用量は、化合物(C)に対して通
常等モル〜5倍モル量、好ましくは等モル〜3倍
モル量とされるのがよく、亜鉛は化合物(C)に対し
て通常等モル〜5倍モル量、好ましくは等モル〜
3倍モル量用いられるのがよい。反応は約50℃と
〜溶媒の沸点温度の範囲で良好に進行する。
かくして得られる化合物(F)の脱水反応は、通常
有機溶媒中、酸触媒の存在下に行なわれる。溶媒
としては、例えばベンゼン、エーテル、クロロホ
ルム、ジクロルメタン等を使用できる。酸触媒と
しては、例えば塩化水素ガス、p−トルエンスル
ホン酸等を使用できる。反応は上記酸の触媒量を
用いて、約0℃〜溶媒の沸点温度範囲にて良好に
進行し、化合物(G)を収得できる。
化合物(G)の加水分解反応は、常法に従い実施さ
れ、特に水酸化アルカリを用いたアルカリ加水分
解法が好ましく採用される。水酸化アルカリは化
合物(G)に対して通常等モル〜20倍モル量の範囲で
用いられ、反応はアルコール、水、これらの混合
溶媒中、約20℃〜溶媒の沸点範囲の温度下に行な
われる。
上記により得られる化合物(H)の水素添加反応
は、通常の接触還元反応に従い、例えば5〜10%
パラジウムカーボン、酸化白金(PtO2)、ラネー
ニツケル等を触媒として用いて、アルコール、酢
酸エチル、DMF、水、エーテル等の溶媒中、常
圧〜10気圧程度の水素圧下に行なわれる。
また上記で得られる化合物(I)は、前述した
CANを用いる酸化反応又はジヨーンズ試薬を用
いる酸化反応に従わせることにより、化合物(J)に
誘導することができる。
反応工程式−1における原料化合物(2)の内
R2′が低級アルコキシカルボニル低級アルキル基
であるものは次の反応工程式−6に示す方法によ
り製造できる。
〔式中R1は前記に同じ。R6はカルボキシアルキ
ル基を、R7は低級アルコキシカルボニルアルキ
ル基を夫々示す。〕
上記によれば、化合物(K)のエステル化反応によ
り、化合物(L)を製造できる。該エステル化反応
は、好ましくはアルカリ存在下に、ハライド類を
用いて行なわれる。ここでハライド類としては低
級アルキルハライド、例えば沃化メチル、塩化メ
チル、沃化イソプロピル等を例示できる。アルカ
リとしては、ピリジン、トリエチルアミン等の有
機アミン類、炭酸カリウム、炭酸ナトリウム等を
利用できる。反応はDMF、DMSO、THF等の極
性溶媒中、約20〜50℃の温度条件下に行なわれ
る。アルカリ及びハライド類の使用量は任意に決
定されるが、通常化合物(K)に対して、夫々約1〜
10倍モル量、好ましくは約1〜5倍モル量とされ
るのがよい。
〔式中R1、R2、R3及びnは前記に同じ。〕
本発明化合物(1)(キノン化合物)は、これを常
法に従い還元することにより、化合物(M)(ハ
イドロキノン化合物)に変換できる。この還元反
応は、例えば塩化第1錫、水素化ホウ素ナトリウ
ム、ナトリウムハイドロサルフアイド等のよく知
られた触媒(接触水添用触媒)を用いて、通常の
方法により行ない得る。例えば塩化第1錫を用い
る場合、反応は塩酸酸性として含水アルコール中
で、化合物(1)に対して等モル〜3倍モル量の
SnCl2・2H2Oを用い約−20〜30℃で行なわれる。
水素化ホウ素ナトリウムの場合、反応は好ましく
アルコール中で、化合物(1)の約1/2〜3倍モル量
の水素化ホウ素ナトリウムを用い、約0〜30℃で
実施される。ナトリウムハイドロサルフアイドの
場合、これは約10%前後の水溶液形態で用いら
れ、反応はアセトン、エーテル、ジオキサン、水
等の溶媒中で約0℃〜沸点の範囲の温度で進行す
る。
また化合物(M)は、空気酸化や塩化第二鉄、
酸化銀等の酸化剤を用いて常法に従い、容易に酸
化され、本発明化合物(1)とすることができる。上
記塩化第二鉄は通常水溶液形態で化合物(M)に
対し当モル〜20倍モル用いられ、この場合、反応
はTHF、アルコール、水等の溶媒中で約0〜30
℃で実施される。また酸化銀は化合物(M)に対
し等モル〜20倍モル用いられ、この場合、反応は
エーテル、アセトン、ジオキサン、THF等の溶
媒中、約0〜30℃で行なわれる。
上記各反応により得られる目的物は、慣用の分
離手段、例えば溶媒抽出、再結晶、カラムクマロ
マトグラフイー等により容易に単離精製すること
ができる。
また本発明化合物(1)中、遊離のカルボキシル基
を有するものは、アルカリ金属塩例えばナトリウ
ム塩、カリウム塩等やアルカリ土類金属塩例えば
カルシウム塩、マグネシウム塩等とすることがで
きる。これらの塩形成反応は常法に従つて行なう
ことができる。かくして得られる塩類も亦、遊離
形態の本発明化合物と同様の薬理活性を有してお
り、本発明範囲に包含される。更に本発明化合物
には光学異性体や幾何異性体が考えられ、かかる
異性体も亦本発明範囲に含まれているものであ
る。
実施例
以下、本発明化合物を製造するための原料化合
物の製造例を参考例として挙げ、次いで本発明化
合物の製造例を実施例として挙げる。
参考例 1
4,5,8−トリメトキシ−1−ナフトアルデ
ヒドの製造
4,8−ジメトキシ−1−ナフトアルデヒド
195gをジメチルホルムアミド(DMF)800mlに
溶解させ、氷冷下、これにN−ブロモコハク酸イ
ミド(NBS)160gのDMF溶液800mlを加える。
反応混合物を1晩撹拌した後、水約8に移し、
折出結晶を取し、水洗する。得られる粗結晶を
減圧下に乾燥して、5−ブロモ−4,8−ジメト
キシ−1−ナフトアルデヒド
240g(90%)を得る。
NMR分析(CDCl3、δ値)
10.78(1H、s)
7.88(1H、d、J=8.3)
7.72(1H、d、J=8.3)
6.93(1H、d、J=8.3)
6.77(1H、d、J=8.3)
3.99(3H、s)
3.97(3H、s)
このものは、精製することなく、次の反応に使用
できる。
次いで、無水メタノール1にナトリウム77.5
gを溶解させた液に、沃化銅(I)(Cu)155g及
びDMF1を加え、得られる混液に上記で得たブ
ロム体240gを加え、1時間還流する。反応混合
物から不純物を別し、母液に水約6を加えて
結晶を析出させ、これを取し、10%塩酸で洗浄
し、次いで水洗し、更にイソプロピルアルコール
次いでエーテルで夫々洗浄して、目的化合物の粗
結晶140g(70%)を得る。
NMR分析(CDCl3、δ値)
10.78(1H、s)
7.91(1H、d、J=8.6)
6.90(1H、d、J=8.6)
6.87(2H、bs)
4.01(3H、s)
3.93(3H、s)
3.91(3H、s)
このものも更に精製せずとも、次の反応に使用
できる。
参考例 2
1−ヒドロキシメチル−4,5,8−トリメト
キシナフタレンの製造
参考例1で得た4,5,8−トリメレトキシ−
1−ナフトアルデヒド8gをエタノール200ml及
びTHF200mlに溶解し、60℃で加温し、撹拌下に
NaBH4の2gを徐々に加える。1時間撹拌の後
に、3%HClにて酸性とし、反応混合物を
CH2Cl2で抽出し、乾燥(MgSO4)し、濃縮後、
得られた粗結晶をクロロホルム・ヘキサン混合溶
媒から再結晶して、6.5g(82%)の目的物を白
色結晶として得る。
融点112.5〜113.5℃
参考例 3
1−メチル−4,5,8−トリメトキシナフタ
レンの製造
参考例1で得た4,5,8−トリメトキシ−1
−ナフトアルデヒド3gを酢酸50ml及び70%
HClO40.1mlに溶解し、10%Pd−C700mgを加え、
常圧下に25℃で水素添加を行なう。撹拌を3.5時
間続け、触媒を別し、液に水を加えCH2Cl2
抽出し、有機層を5%NaHCO3水溶液で洗い、
その後水洗、乾燥(MgSO4)及び濃縮して得ら
れる結晶を、クロロホルム・ヘキサン混合溶媒で
再結晶して、1.95g(70%)の白色結晶の目的物
を得る。融点95〜96.5℃
参考例 4
3−〔1−(4,5,8−トリメトキシ)ナフチ
ル)アクリル酸
4,5,8−トリメトキシナフトアルデヒド23
g、亜鉛板20g及びベンゼン600mlの混合液に、
ブロム酢酸メチル28mlを還流撹拌下、約1時間を
要して加える。その後、30分加熱還流を続けた
後、反応混合物を水に移し、不溶物を別、塩化
メチレンで洗い、液を塩化メチレンで抽出す
る。乾燥(MgSO4)、濃縮後、カラムクロマトグ
ラフイー(シリカゲル、塩化メチレン:酢酸エチ
ル=3:1)で精製すると、3−ヒドロキシ−3
−〔1−(4,5,8−トリメトキシ)ナフチル〕
プロピオン酸メチルエステル12g(40%)を淡黄
色結晶として得る。
融点105〜107℃
次いで上記で得た化合物10gをクロロホルム
500mlに溶解し、エタノール性塩酸(90gHClガ
ス/900mlEtOH)5mlを加え、室温で2.5時間放
置する。その後、無水K2CO3で乾燥後、溶媒留
去し、得られた結晶を、クロロホルム:ヘキサン
混合溶媒で再結晶すると9g(95%)の脱水生成
物を黄色結晶として得る。この様にして得られた
3−〔1−(4,5,8−トリメトキシ)ナフチ
ル〕アクリル酸メチルエステル4.3gをメタノー
ル150ml及び2NNaOH70mlに混合し、30分還流す
る。冷却後、濃塩酸にて酸性にし、析出する結晶
を取、水洗する。黄色結晶を乾燥すると4g
(97%)で3−〔1−(4,5,8−トリメトキシ)
ナフチル〕アクリル酸を得る。
参考例 5
3−〔1−(4,5,8−トリメトキシ)ナフチ
ル〕プロピオン酸の製造
参考例4で得た3−〔1−(4,5,8−トリメ
トキシ)ナフチル〕アクリル酸4gをDMF300ml
及びエタノール300mlに溶解し、10%Pd−C1gを
加え、常圧下に25℃にて水素添加する。約2時間
後、触媒を別し、溶媒を留去し、得られた結晶
をクロロホルム・ヘキサン混合溶媒から再結晶し
て3.7g(92%)の目的物を得る。
融点168〜170℃
参考例 6
5−ヒドロキシメチル−8−メトキシ−1,4
−ナフトキノンの製造
1−ヒドロキシメチル−4,5,8−トリメト
キシナフタレン8gを塩化メチレン100mlに溶解
し、その中にCAN44gを水150mlに溶解したもの
を加え、15分間撹拌し、その後有機層を水洗し、
乾燥(MgSO4)し、濃縮して得られる結晶を、
クロロホルム・エチルエーテル混合溶媒で再結晶
して、5.3g(75%)の黄色結晶の目的物を得る。
融点165〜167℃(分解)
同様の操作で、1−メチル−4,5,8−トリ
メトキシナフタレンから、黄色結晶の5−メチル
−8−メトキシ−1,4−ナフトキノンを得る。
融点116〜117.5℃
参考例 7
5−(2−カルボキシエチル)−8−メトキシ−
1,4−ナフトキノンの製造
3−〔1−(4,5,8−トリメトキシ)ナフチ
ル〕プロピオン酸5gを、アセトン500mlに溶解
し、氷冷下ジヨーンズ試薬36mlを加え、30分間撹
拌する。反応混合物を水に移し、塩化メチレン抽
出し、有機層を乾燥(MgSO4)し、濃縮して得
られる粗結晶をクロロホルム・エチルエーテル混
合溶媒で再結晶して、3gの黄色結晶の目的物を
得る。
融点167〜168.5℃(分解)
参考例 8
5−(2−メトキシカルボニルエチル)−8−メ
トキシ−1,4−ナフトキノンの製造
5−(2−カルボキシエチル)−8−メトキシ−
1,4−ナフトキノン2.6g、K2CO32.5g及び沃
化メチル3mlをDMF50mlに混合し、25℃で16時
間撹拌する。反応混合物を水に移し、酢酸エチル
で抽出し、有機層を水洗、乾燥(MgSO4)及び
濃縮し、得られる結晶を酢酸エチル・ヘキサン混
合溶媒で再結晶して、2g(72%)の黄色結晶の
目的物を得る。
融点123.5〜125℃
実施例 1
8−ヒドロキシメチル−5−メトキシ−2−ベ
ンゼンスルフエニル−1,4−ナフトキノンの
製造
8−ヒドロキシメチル−5−メトキシ−1,4
−ナフトキノン1.0g、チオフエノール510mg、エ
タノール60ml及びDMF20mlの混合物を5時間撹
拌する。その後10%FeCl3溶液50mlを加え、1時
間更に撹拌を続ける。反応混合物を水に移し、酢
酸エチルで析出し、有機層を水洗、乾燥
(MgSO4)、濃縮して得られる結晶を酢酸エチ
ル:エーテルの混合溶媒から再結晶して900mgの
目的化合物を黄色結晶として得た。
融点144〜145℃(分解)1
H−NMR(CDCl3)
7.71(1H、d、J=8.1Hz)
7.26(1H、d、J=8.1Hz)
7.50(5H、bs)
6.00(1H、s)
4.74(2H、d、J=7.2Hz)
4.02(3H、s)
3.07(1H、t、J=7.2Hz)
実施例 2〜20
実施例1と同様にして下記第1表に示す各化合
物を得る。
尚第1表には実施例1で得た化合物も併記す
る。
INDUSTRIAL APPLICATION FIELD The present invention relates to naphthoquinone derivatives. Prior Art The naphthoquinone derivative of the present invention is a novel compound that has not been described in any literature. Problems to be Solved by the Invention The present invention aims to provide a compound useful as a pharmaceutical, as described later. Means for Solving the Problems According to the present invention, a naphthoquinone derivative represented by the following general formula (1) is provided. [In the formula, R 1 represents a lower alkyl group. R 2 is a lower alkyl group that may have a hydroxyl group as a substituent, a lower alkoxycarbonyl lower alkyl group,
lower alkylcarbonyloxy lower alkyl group,
Lower alkoxycarbonyloxy lower alkyl group, carboxy lower alkyl group or benzoyloxy lower alkyl group. R 3 is an alkyl group,
Hydroxy lower alkyl group, phenyl group that may have a lower alkyl group, halogen atom, lower alkoxy group, carboxy group, or carboxy lower alkyl group as a substituent, phenyl that may have a lower alkoxy group as a substituent on the phenyl ring It represents a lower alkyl group, a lower alkoxycarbonyl lower alkyl group, or a furanyl lower alkyl group. n represents 0, 1 or 2] In this specification, the term lower alkyl group is
It refers to a linear or branched alkyl group having 1 to 6 carbon atoms, and specific examples include methyl, ethyl, propyl, isopropyl, butyl,
Examples include isobutyl, sec-butyl, tert-butyl, pentyl, and hexyl groups. In addition to the above-mentioned lower alkyl groups, the term alkyl group includes, for example, octyl, nonyl, decyl, undecyl, dodecyl,
Tetradecyl, hexadecyl, octadecyl, eicosyl groups, etc. are included. The term lower alkoxy group refers to a straight or branched alkoxy group having 1 to 6 carbon atoms, examples of which include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butyloxy, and pentyloxy. ,
Examples include hexyloxy groups. Halogen atoms include chlorine, fluorine, iodine and bromine atoms. In general formula (1), the lower alkoxycarbonyl lower alkyl group, lower alkylcarbonyloxy lower alkyl group and lower alkoxycarbonyloxy lower alkyl group defined in R 2 and R 3 are all the above-mentioned lower alkyl group or lower It contains an alkoxy group and the above lower alkyl group as constituent components. The carboxy lower alkyl group, benzoyloxy lower alkyl group and hydroxy lower alkyl group are the above-mentioned lower alkyl groups having a carboxy group, benzoyloxy group or hydroxy group as a substituent. Examples of phenyl lower alkyl groups that may have a lower alkoxy group as a substituent on the phenyl ring include benzyl, phenethyl,
Examples include unsubstituted phenyl lower alkyl groups such as phenylpropyl, phenylbutyl, phenylpentyl, and phenylhexyl groups, and lower alkoxy-substituted phenyl lower alkyl groups such as methoxybenzyl, ethoxybenzyl, methoxyphenethyl, and ethoxyphenylbutyl groups. Furthermore, a phenyl group that may have a lower alkyl group, a halogen atom, a lower alkoxy group, a carboxy group, or a carboxy lower alkyl group as a substituent may have a plurality of each of the above substituents on the phenyl ring, In this case, the substituents may be the same or different. The compound represented by the above general formula (1) of the present invention and its salt have an effect of blocking or regulating prostaglandin biosynthesis, and have anti-inflammatory, anti-rheumatic, anti-allergic, anti-inflammatory effects on animals, especially mammals. It exhibits effects such as pain, diuresis, platelet aggregation inhibition, and blood pressure lowering.
Therefore, it is useful as a medicine such as an anti-inflammatory agent, an anti-rheumatic agent, an anti-allergic agent, a pain agent, a diuretic, an antithrombotic agent, and an antihypertensive agent. The naphthoquinone derivative of the present invention can be produced, for example, by the method shown in each reaction scheme-1 below. [In the formula, R 1 , R 2 and R 3 are the same as above. R 2 ′ represents a lower alkyl group, lower alkoxycarbonyl lower alkyl group, or carboxy lower alkyl group that may have a hydroxyl group as a substituent, and R 2 ″ represents a lower alkylcarbonyloxy lower alkyl group, a lower alkoxycarbonyloxy lower alkyl group. or a benzoyloxy lower alkyl group.m is 1
shows. ] In Reaction Scheme-1, the reaction between compound (2) and the thiol compound (R 3 SH) is carried out in an inert solvent. Examples of the solvent that can be used include lower alcohols such as methanol and ethanol, N,N-dimethylformamide (DMF), tetrahydrofuran (THF), dioxane, water, and mixed solvents thereof. The reaction is preferably carried out under an inert gas atmosphere such as nitrogen or argon, using a thiol compound in an amount of usually 0.5 to 2 times, preferably about 1 to 1.1 times the amount of compound (2), at about 0°C to a solvent temperature. This is carried out at about the boiling point of , preferably about 20 to 80°C, for about 1 to 50 hours. The above reaction produces an intermediate with the general formula A condensate represented by the formula [wherein R 1 , R 2 ' and R 3 are the same as above] is obtained. The condensate is then oxidized by adding an excess amount of an aqueous solution of ferric chloride into the reaction system or by blowing oxygen (air) into the reaction system, thereby obtaining compound (1-a). The obtained compound (1-a) can be easily converted into a sulfinyl form of compound (1-c) by oxidizing it. This oxidation reaction is carried out using an appropriate oxidizing agent, such as periodate salts such as sodium periodate and potassium periodate, organic peracids such as peracetic acid and m-chloroperbenzoic acid, and hydrogen peroxide. It can be carried out according to conventional methods. For more details,
The above oxidation reaction is carried out in lower alcohols such as methanol and ethanol, halogenated hydrocarbons such as dichloromethane and chloroform, organic solvents such as acetone, dioxane and acetic acid, or water-containing solvents thereof. The above-mentioned oxidizing agent is used in an amount of about 1 to 1.2 times the molar amount of the compound (1-a), for example, in the case of an organic peracid. The reaction is carried out at a temperature of about -20 to 30°C over a period of about 10 to 60 minutes. Further, among compounds (1-a), compounds in which R 2 ' is a lower alkyl group having a hydroxyl group as a substituent,
By reacting this with an appropriate acid halide, the hydroxyl group is acylated to form compound (1-b).
It can be done. The acylation reaction is carried out in an aprotic solvent, preferably in the presence of an alkali, according to a conventional method. Examples of aprotic solvents that can be used include halogenated hydrocarbons such as dichloromethane and chloroform, ethers such as THF and dioxane, aromatic hydrocarbons such as benzene and toluene, and dimethyl sulfoxide (DMSO). Examples of acid halides used as acylating agents include halides of lower fatty acids such as acetyl chloride, acetyl bromide, and propionyl chloride; carbo-lower alkoxy chlorides such as carbomethoxy chloride, carboethoxy chloride, and carbopropoxy chloride; and benzoyl chloride. Examples include benzoyl halide. Examples of the alkali include organic amines such as pyridine and triethylamine, and inorganic compounds such as potassium carbonate and sodium carbonate. The amounts of acid halide and alkali to be used are not limited, but are usually about 1 to 5 times the molar amount, preferably about 1 to 1.5 times the molar amount of each compound (1-a). The above acylation reaction is generally carried out at a temperature of about 0 to 60°C, and is completed in about 0.5 to 5 hours, thus yielding compound (1-b). The oxidation reaction of the compound (1-b) is carried out in the same manner as the oxidation reaction of the above-mentioned compound (1-a), whereby the compound (1-c) can be obtained. The target products obtained by each of the above reactions can be easily isolated and purified by conventional separation means such as solvent extraction, recrystallization, column chromatography, etc. The compound used as a starting material in the above reaction scheme-1 can be obtained, for example, according to the following reaction scheme. [In each formula, R 1 is the same as above. ] The compound (A) used as the starting material in the above reaction scheme-2 is known [J.Org.Chem., 44 , 2153
(1979)]. Bromination of compound (A) can be carried out, for example, by N-
This is carried out using a brominating agent such as bromosuccinimide (NBS). The brominating agent is preferably used in an equimolar amount to compound (A), and the reaction is carried out in an amount of about 0 to
It progresses well under the temperature condition of 80°C and is completed in about 2 to 16 hours. The lower alkoxylation of the compound (B) obtained above was carried out using methanol,
DMF using a sodium salt of a lower alcohol such as ethanol in an amount of 1 to 4 times the amount of compound (B).
and lower alcohols in a mixed solvent of about 80 to 120
It takes about 1 to 4 hours to carry out at ℃. At that time, copper salts such as cupric chloride, cuprous iodide, etc. are added to the compound (B).
The reaction will proceed more favorably if about 1/2 to 2 times the molar amount is used. Compound (C) is thus obtained. [In the formula, R 1 is the same as above. R 4 is a lower alkyl group or benzyloxy lower alkyl group, R 4 ′ is a lower alkyl group that may have a hydroxyl group as a substituent, R 4 ″ is a lower alkyl group or carboxy lower alkyl group that may have a hydroxyl group as a substituent The Grignard reaction of the above-mentioned compound (C) can be carried out according to a conventional method, that is, using a Grignard reagent in a suitable solvent at about -20 to 60°C, preferably about 0 to 25°C. The Grignard reagent is prepared according to a conventional method by adding, for example, an alkyl halide, a phenyl lower alkyl halide, or a lower alkenyl halide and about 1.1 to 1.2 times the molar amount of magnesium per mole of these halides. It can be easily prepared from.As a solvent, ordinary ether, THF, etc. can be used.The amount of the Grignard reagent to be used is usually 1 to 5 times the molar amount of compound (C), preferably 5 times the molar amount of compound (C). It is desirable to set the amount at which the yellow color originally exhibited by the solvent solution disappears, which is usually about equimolar to 4 times the molar amount.
1) is obtained. The dehydration reaction of compound (C-1) is usually carried out in an organic solvent in the presence of an acid catalyst. Examples of solvents include benzene, ether, chloroform,
Dichloromethane etc. can be used. As the acid catalyst, for example, hydrogen chloride gas, p-toluenesulfonic acid, etc. can be used. The reaction proceeds well using a catalytic amount of the above-mentioned acid in a temperature range of about 0° C. to the boiling point of the solvent. The catalytic reduction reaction following the above dehydration reaction is carried out according to a conventional method, for example, using 5 to 10% palladium on carbon,
Alcohol, ethyl acetate , DMF, water,
The reaction is carried out in a solvent such as ether under a hydrogen pressure of about 3 atm from normal pressure. In this way, debenzination of the raw material compound and reduction of double bonds are performed simultaneously, and compound (C-2) can be obtained. The oxidation reaction of compound (C-2) is carried out, for example, by the following two methods depending on the type of R 4 ″ group possessed by the target compound (C-3).
When producing a compound in which R 4 ″ is a lower alkyl group that may have a hydroxyl group as a substituent, the above oxidation reaction is preferably carried out using seric ammonium nitrate [(NH 4 ) 2 Cl(NO 3 ) 6 , hereinafter “ CAN] or silver oxide (AgO) in dilute nitric acid. The above method using CAN includes, for example, dioxane, acetonitrile, THF, dichloromethane,
In a solvent such as chloroform or ether, the compound (C
-2) using CAN in an equivalent molar amount to 5 times the molar amount, preferably 2 to 2.5 times the molar amount, about -20 to 60 ° C.
Preferably, the temperature is about 0 to 30°C. in dilute nitric acid
In the method using AgO, a compound (C
-2) using an equimolar to 20 times molar amount, preferably about 3 to 10 times the molar amount of AgO and about 6N nitric acid, at a temperature of 0 to the boiling point of the solvent, preferably 0 to 60°C. Implemented. In addition, when producing a compound in which the R 4 ′ group is a carboxy lower alkyl group, the above oxidation reaction is performed using a Jones reagent to prepare the compound (C-2) in which R 4 ′ is a lower alkyl group having a hydroxyl group. Method [Reagents for
Organic Synthesis, Vol1, 142 , Wiley, New
York, 1967].
That is, the oxidation reaction is carried out using acetone, dioxane, ether, etc., preferably acetone, as a solvent at a temperature of about 0 to 30°C. The amount of John's reagent used is suitably an equivalent molar to 20 times the amount of croic acid, preferably 2 to 8 times the molar amount of compound (C-2). The raw material compound (C-
The hydroxyl group of 2) is converted into a carboxyl group, and at the same time, a naphthoquinone ring is formed by oxidation of the naphthalene ring, yielding the desired compound (C-3). Among the starting materials (2) in reaction scheme-1,
Those in which R 2 ' is a methyl group or a hydroxymethyl group can be produced by a reduction reaction of compound (C) according to the following reaction scheme-4 and a subsequent oxidation reaction of the product compound (D). [In the formula, R 1 is the same as above. R 2 〓 represents a methyl group or a hydroxymethy group. ] In the above, the reduction reaction of compound (C) can be carried out by a method using a hydride such as NaBH 4 or LiAlH 4 or by catalytic reduction according to a known method.
According to the reduction reaction using hydride, a compound (D) in which R 2 is a hydroxymethyl group can be obtained. The catalytic reduction is carried out according to a conventional method, preferably using a small amount (catalytic amount) of perchloric acid, in the presence of a catalyst such as 5-10% palladium on carbon, PtO 2 , Raney nickel, alcohol, ethyl acetate, DMF,
The reaction is carried out in a solvent such as water or ether under a hydrogen pressure of about normal pressure to about 10 atm, whereby a compound (D) in which R 2 〓 is a methyl group can be obtained. The oxidation reaction of the compound (D) thus obtained is carried out in the same manner as the oxidation reaction using CAN described above, thereby producing the compound (E). Among the compounds (C-3) shown in reaction scheme-3,
In particular, those in which R 4 ″ is a carboxymethyl group can also be obtained by the method shown in the following reaction scheme-5. [In each formula, R 1 is the same as above. R 5 represents a lower alkyl group. ] According to the above method, compound (F) can be obtained by carrying out the carburizing reaction of compound (C) according to the Reformatsky reaction. The reaction is carried out by condensing compound (C) with α-haloacetate in a solvent such as benzene, toluene, xylene, etc. in the presence of zinc or the like. As the α-haloacetic acid ester, bromoacetic acid lower alkyl ester is preferably used. The amount used is usually equimolar to 5 times the molar amount, preferably equimolar to 3 times the molar amount of the compound (C), and zinc is usually equimolar to 5 times the molar amount of the compound (C). 5 times the molar amount, preferably equimolar to
It is preferable to use 3 times the molar amount. The reaction proceeds well at temperatures between about 50°C and the boiling point of the solvent. The dehydration reaction of the compound (F) thus obtained is usually carried out in an organic solvent in the presence of an acid catalyst. As the solvent, for example, benzene, ether, chloroform, dichloromethane, etc. can be used. As the acid catalyst, for example, hydrogen chloride gas, p-toluenesulfonic acid, etc. can be used. Using a catalytic amount of the above-mentioned acid, the reaction proceeds well in the temperature range of about 0° C. to the boiling point of the solvent, and Compound (G) can be obtained. The hydrolysis reaction of compound (G) is carried out according to a conventional method, and an alkaline hydrolysis method using an alkali hydroxide is particularly preferably employed. The alkali hydroxide is usually used in an equimolar to 20 times the molar amount of compound (G), and the reaction is carried out in alcohol, water, or a mixed solvent thereof at a temperature ranging from about 20°C to the boiling point of the solvent. It will be done. The hydrogenation reaction of the compound (H) obtained above is carried out according to the usual catalytic reduction reaction, for example, 5 to 10%
The reaction is carried out using palladium carbon, platinum oxide (PtO 2 ), Raney nickel, etc. as a catalyst in a solvent such as alcohol, ethyl acetate, DMF, water, ether, etc. under a hydrogen pressure of from normal pressure to about 10 atmospheres. Moreover, the compound (I) obtained above is
Compound (J) can be derived by subjecting it to an oxidation reaction using CAN or an oxidation reaction using Jones's reagent. Of the raw material compounds (2) in reaction scheme-1
Those in which R 2 ' is a lower alkoxycarbonyl lower alkyl group can be produced by the method shown in the following reaction scheme-6. [In the formula, R 1 is the same as above. R 6 represents a carboxyalkyl group, and R 7 represents a lower alkoxycarbonylalkyl group. ] According to the above, compound (L) can be produced by esterification reaction of compound (K). The esterification reaction is preferably carried out using halides in the presence of an alkali. Examples of the halides include lower alkyl halides such as methyl iodide, methyl chloride, and isopropyl iodide. As the alkali, organic amines such as pyridine and triethylamine, potassium carbonate, sodium carbonate, etc. can be used. The reaction is carried out in a polar solvent such as DMF, DMSO, THF, etc. at a temperature of about 20-50°C. The amounts of alkali and halides to be used can be determined arbitrarily, but usually about 1 to 1 to 1,000 ml each per compound (K).
The amount is preferably 10 times the molar amount, preferably about 1 to 5 times the molar amount. [In the formula, R 1 , R 2 , R 3 and n are the same as above. ] The compound (1) of the present invention (quinone compound) can be converted to compound (M) (hydroquinone compound) by reducing it according to a conventional method. This reduction reaction can be carried out by a conventional method using well-known catalysts (catalytic hydrogenation catalysts) such as stannous chloride, sodium borohydride, and sodium hydrosulfide. For example, when using stannous chloride, the reaction is carried out in an aqueous alcohol under the acidity of hydrochloric acid in an amount of equimolar to 3 times the molar amount of compound (1).
It is carried out using SnCl 2 .2H 2 O at about -20 to 30°C.
In the case of sodium borohydride, the reaction is preferably carried out in an alcohol using about 1/2 to 3 times the molar amount of sodium borohydride as compound (1) at about 0 to 30°C. In the case of sodium hydrosulfide, it is used in the form of an aqueous solution of around 10% and the reaction proceeds in a solvent such as acetone, ether, dioxane, water, etc. at temperatures ranging from about 0°C to the boiling point. Compound (M) can also be prepared by air oxidation, ferric chloride,
It can be easily oxidized to the compound (1) of the present invention using an oxidizing agent such as silver oxide according to a conventional method. The above-mentioned ferric chloride is usually used in the form of an aqueous solution in an amount of equivalent to 20 times the mole of compound (M), and in this case, the reaction is carried out in a solvent such as THF, alcohol, water, etc.
Conducted at °C. Further, silver oxide is used in an amount of equimolar to 20 times the molar amount of compound (M), and in this case, the reaction is carried out in a solvent such as ether, acetone, dioxane, THF, etc. at about 0 to 30°C. The target products obtained by each of the above reactions can be easily isolated and purified by conventional separation means such as solvent extraction, recrystallization, column chromatography, etc. Among the compounds (1) of the present invention, those having a free carboxyl group can be alkali metal salts, such as sodium salts, potassium salts, etc., and alkaline earth metal salts, such as calcium salts, magnesium salts, etc. These salt-forming reactions can be carried out according to conventional methods. The salts thus obtained also have the same pharmacological activity as the free form of the compound of the present invention and are included within the scope of the present invention. Further, the compounds of the present invention may have optical isomers and geometric isomers, and such isomers are also included within the scope of the present invention. Examples Hereinafter, production examples of raw material compounds for producing the compounds of the present invention will be listed as reference examples, and then production examples of the compounds of the present invention will be listed as examples. Reference Example 1 Production of 4,5,8-trimethoxy-1-naphthaldehyde 4,8-dimethoxy-1-naphthaldehyde
Dissolve 195 g in 800 ml of dimethylformamide (DMF), and add 800 ml of a DMF solution of 160 g of N-bromosuccinimide (NBS) to this under ice cooling.
The reaction mixture was stirred overnight and then transferred to approx.
Take the precipitated crystals and wash them with water. The resulting crude crystals are dried under reduced pressure to obtain 240 g (90%) of 5-bromo-4,8-dimethoxy-1-naphthaldehyde. NMR analysis (CDCl 3 , δ value) 10.78 (1H, s) 7.88 (1H, d, J=8.3) 7.72 (1H, d, J=8.3) 6.93 (1H, d, J=8.3) 6.77 (1H, d , J=8.3) 3.99 (3H, s) 3.97 (3H, s) This product can be used in the next reaction without purification. Then, 77.5 parts sodium to 1 part absolute methanol
155 g of copper (I) iodide (Cu) and 1 DMF are added to the solution in which g is dissolved, and 240 g of the bromine compound obtained above is added to the resulting mixed solution, and the mixture is refluxed for 1 hour. Impurities were separated from the reaction mixture, and about 6 g of water was added to the mother liquor to precipitate crystals, which were collected and washed with 10% hydrochloric acid, then with water, and then with isopropyl alcohol and then with ether to obtain the target compound. 140 g (70%) of crude crystals are obtained. NMR analysis (CDCl 3 , δ value) 10.78 (1H, s) 7.91 (1H, d, J = 8.6) 6.90 (1H, d, J = 8.6) 6.87 (2H, bs) 4.01 (3H, s) 3.93 (3H , s) 3.91 (3H, s) This product can also be used in the next reaction without further purification. Reference Example 2 Production of 1-hydroxymethyl-4,5,8-trimethoxynaphthalene 4,5,8-trimethoxy-naphthalene obtained in Reference Example 1
8 g of 1-naphthaldehyde was dissolved in 200 ml of ethanol and 200 ml of THF, heated at 60°C, and stirred.
Gradually add 2g of NaBH4 . After stirring for 1 hour, the reaction mixture was acidified with 3% HCl.
After extraction with CH2Cl2 , drying ( MgSO4 ) and concentration,
The obtained crude crystals are recrystallized from a mixed solvent of chloroform and hexane to obtain 6.5 g (82%) of the desired product as white crystals. Melting point: 112.5-113.5°C Reference Example 3 Production of 1-methyl-4,5,8-trimethoxynaphthalene 4,5,8-trimethoxy-1 obtained in Reference Example 1
- 3 g of naphthaldehyde in 50 ml of acetic acid and 70%
Dissolved in 0.1 ml of HClO 4 and added 700 mg of 10% Pd-C.
Hydrogenation is carried out at 25°C under normal pressure. Stirring was continued for 3.5 hours, the catalyst was separated, water was added to the liquid and CH 2 Cl 2
Extract, wash the organic layer with 5% NaHCO3 aqueous solution,
Thereafter, the crystals obtained by washing with water, drying (MgSO 4 ), and concentration are recrystallized from a mixed solvent of chloroform and hexane to obtain 1.95 g (70%) of the desired product as white crystals. Melting point 95-96.5℃ Reference example 4 3-[1-(4,5,8-trimethoxy)naphthyl)acrylic acid 4,5,8-trimethoxynaphthaldehyde 23
g, a mixed solution of 20 g of zinc plate and 600 ml of benzene,
Add 28 ml of methyl bromoacetate over about 1 hour while stirring at reflux. Thereafter, after continuing to heat under reflux for 30 minutes, the reaction mixture was transferred to water, the insoluble matter was separated and washed with methylene chloride, and the liquid was extracted with methylene chloride. After drying (MgSO 4 ), concentration, and purification by column chromatography (silica gel, methylene chloride: ethyl acetate = 3:1), 3-hydroxy-3
-[1-(4,5,8-trimethoxy)naphthyl]
12 g (40%) of propionic acid methyl ester are obtained as pale yellow crystals. Melting point: 105-107°C Next, 10g of the compound obtained above was added to chloroform.
Dissolve in 500 ml, add 5 ml of ethanolic hydrochloric acid (90 g HCl gas/900 ml EtOH), and leave at room temperature for 2.5 hours. Thereafter, after drying with anhydrous K 2 CO 3 , the solvent is distilled off, and the obtained crystals are recrystallized from a mixed solvent of chloroform and hexane to obtain 9 g (95%) of a dehydrated product as yellow crystals. 4.3 g of 3-[1-(4,5,8-trimethoxy)naphthyl]acrylic acid methyl ester thus obtained was mixed with 150 ml of methanol and 70 ml of 2NNaOH, and the mixture was refluxed for 30 minutes. After cooling, acidify with concentrated hydrochloric acid, remove precipitated crystals, and wash with water. 4g of yellow crystals when dried
(97%) in 3-[1-(4,5,8-trimethoxy)
Obtain naphthyl acrylic acid. Reference Example 5 Production of 3-[1-(4,5,8-trimethoxy)naphthyl]propionic acid 4 g of 3-[1-(4,5,8-trimethoxy)naphthyl]acrylic acid obtained in Reference Example 4 was added to 300 ml of DMF.
The mixture was dissolved in 300 ml of ethanol, 1 g of 10% Pd-C was added, and hydrogenated at 25°C under normal pressure. After about 2 hours, the catalyst is separated, the solvent is distilled off, and the resulting crystals are recrystallized from a mixed solvent of chloroform and hexane to obtain 3.7 g (92%) of the desired product. Melting point 168-170℃ Reference example 6 5-hydroxymethyl-8-methoxy-1,4
-Production of naphthoquinone 8 g of 1-hydroxymethyl-4,5,8-trimethoxynaphthalene was dissolved in 100 ml of methylene chloride, and 44 g of CAN dissolved in 150 ml of water was added thereto, stirred for 15 minutes, and then the organic layer was separated. Wash with water,
The crystals obtained by drying (MgSO 4 ) and concentrating are
Recrystallize with a mixed solvent of chloroform and ethyl ether to obtain 5.3 g (75%) of the desired product as yellow crystals. Melting point: 165-167°C (decomposed) Yellow crystals of 5-methyl-8-methoxy-1,4-naphthoquinone are obtained from 1-methyl-4,5,8-trimethoxynaphthalene in a similar manner. Melting point 116-117.5℃ Reference example 7 5-(2-carboxyethyl)-8-methoxy-
Production of 1,4-naphthoquinone 5 g of 3-[1-(4,5,8-trimethoxy)naphthyl]propionic acid is dissolved in 500 ml of acetone, 36 ml of Johns reagent is added under ice cooling, and the mixture is stirred for 30 minutes. The reaction mixture was transferred to water, extracted with methylene chloride, and the organic layer was dried (MgSO 4 ) and concentrated. The crude crystals obtained were recrystallized from a mixed solvent of chloroform and ethyl ether to obtain 3 g of the target compound as yellow crystals. obtain. Melting point 167-168.5°C (decomposition) Reference example 8 Production of 5-(2-methoxycarbonylethyl)-8-methoxy-1,4-naphthoquinone 5-(2-carboxyethyl)-8-methoxy-
2.6 g of 1,4-naphthoquinone, 2.5 g of K 2 CO 3 and 3 ml of methyl iodide are mixed in 50 ml of DMF and stirred at 25° C. for 16 hours. The reaction mixture was transferred to water, extracted with ethyl acetate, the organic layer was washed with water, dried (MgSO 4 ) and concentrated, and the resulting crystals were recrystallized from a mixed solvent of ethyl acetate and hexane to give 2 g (72%) of yellow Obtain the crystal object. Melting point 123.5-125°C Example 1 Production of 8-hydroxymethyl-5-methoxy-2-benzenesulfenyl-1,4-naphthoquinone 8-hydroxymethyl-5-methoxy-1,4
- A mixture of 1.0 g of naphthoquinone, 510 mg of thiophenol, 60 ml of ethanol and 20 ml of DMF is stirred for 5 hours. Thereafter, 50 ml of 10% FeCl 3 solution was added and stirring was continued for an additional hour. The reaction mixture was transferred to water and precipitated with ethyl acetate. The organic layer was washed with water, dried (MgSO 4 ), and concentrated. The resulting crystals were recrystallized from a mixed solvent of ethyl acetate and ether to give 900 mg of the target compound as yellow crystals. obtained as. Melting point 144-145℃ (decomposition) 1 H-NMR (CDCl 3 ) 7.71 (1H, d, J = 8.1Hz) 7.26 (1H, d, J = 8.1Hz) 7.50 (5H, bs) 6.00 (1H, s) 4.74 (2H, d, J = 7.2Hz) 4.02 (3H, s) 3.07 (1H, t, J = 7.2Hz) Examples 2 to 20 Each compound shown in Table 1 below is obtained in the same manner as in Example 1. . Note that Table 1 also lists the compounds obtained in Example 1.
【表】【table】
【表】
実施例 21
8−ヒドロキシメチル−5−メトキシ−2−n
−ブタンスルフイニル−1,4−ナフトキノン
の製造
8−ヒドロキシメチル−5−メトキシ−2−n
−ブタンスルフエニル−1,4−ナフトキノン
1.6gを塩化メチレン150mlに溶解し、氷冷下、m
−クロル過安息香酸(70%)1.3gを徐々に加え、
その後15分間撹拌を続ける。不溶物を別し、
液を5%NaHCO3水溶液で洗い、その後水洗、
乾燥(MgSO4)、濃縮して得られる化合物を、シ
リカゲルクロマトグラフイーに付し、クロロホル
ムにて展開して1gの目的化合物を黄色結晶とし
て得る。
融点139.5〜141℃(分解)
NMR(CDCl3)
7.85(1H、d、J=8.5Hz)
7.31(1H、d、J=8.5Hz)
6.50(1H、s)
4.83(2H、d、J=7.0Hz)
4.01(3H、s)
3.37(1H、t、J=7.0Hz)
2.81(2H、t、J=7.0Hz)
1.3−1.8(4H、m)
0.97(3H、t、J=6.6Hz)
実施例 22〜25
実施例21と同様にして下記第2表に示す各化合
物を得る。
尚第2表には実施例21の化合物も併記する。[Table] Example 21 8-hydroxymethyl-5-methoxy-2-n
-Production of butanesulfinyl-1,4-naphthoquinone 8-hydroxymethyl-5-methoxy-2-n
-butanesulfenyl-1,4-naphthoquinone
Dissolve 1.6 g in 150 ml of methylene chloride and add m
- Gradually add 1.3 g of chlorperbenzoic acid (70%);
Then continue stirring for 15 minutes. Separate the insoluble matter,
Wash the solution with 5% NaHCO 3 aqueous solution, then with water,
The compound obtained by drying (MgSO 4 ) and concentration is subjected to silica gel chromatography and developed with chloroform to obtain 1 g of the target compound as yellow crystals. Melting point 139.5-141℃ (decomposition) NMR (CDCl 3 ) 7.85 (1H, d, J = 8.5Hz) 7.31 (1H, d, J = 8.5Hz) 6.50 (1H, s) 4.83 (2H, d, J = 7.0 Hz) 4.01 (3H, s) 3.37 (1H, t, J = 7.0Hz) 2.81 (2H, t, J = 7.0Hz) 1.3-1.8 (4H, m) 0.97 (3H, t, J = 6.6Hz) Implementation Examples 22 to 25 The compounds shown in Table 2 below are obtained in the same manner as in Example 21. Note that the compound of Example 21 is also listed in Table 2.
【表】
実施例 26
8−アセトキシメチル−5−メトキシ−2−p
−トルエンスルフエニル−1,4−ナフトキノ
ンの製造
8−ヒドロキシメチル−5−メトキシ−2−p
−トルエンスルフエニル−1,4−ナフトキノン
680mgをクロロホルム10mlに溶解し、ピリジン200
mg存在下にアセチルクロライド150mgのクロロホ
ルム2ml溶液を氷冷下滴下する。その後1時間撹
拌を続けた後、反応混合物を水に移し、クロロホ
ルムで抽出し、有機層を水洗、乾燥(MgSO4)、
濃縮して得られる化合物をシリカゲルクロマトグ
ラフイーに付しクロロホルム:n−ヘキサン混合
溶媒で展開して540mgの目的化合物を黄色結晶と
して得る。
融点148〜150℃(分解)
NMR(CDCl3)
7.73(1H、d、J=8.8Hz)
7.41(2H、d、J=8.3Hz)
7.35(1H、d、J=8.9Hz)
7.26(2H、d、J=8.3Hz)
6.00(1H、s)
5.57(2H、s)
3.96(3H、s)
2.41(3H、s)
2.18(3H、s)
実施例 27及び28
実施例26と同様にして下記第3表に示す各化合
物を得る。
尚第3表には実施例26の化合物も併記する。[Table] Example 26 8-acetoxymethyl-5-methoxy-2-p
-Production of toluenesulfenyl-1,4-naphthoquinone 8-hydroxymethyl-5-methoxy-2-p
-Toluenesulfenyl-1,4-naphthoquinone
Dissolve 680 mg in 10 ml of chloroform and add 200 mg of pyridine.
A solution of 150 mg of acetyl chloride in 2 ml of chloroform was added dropwise under ice cooling. After continuing stirring for 1 hour, the reaction mixture was transferred to water, extracted with chloroform, and the organic layer was washed with water, dried (MgSO 4 ),
The compound obtained by concentration is subjected to silica gel chromatography and developed with a mixed solvent of chloroform and n-hexane to obtain 540 mg of the target compound as yellow crystals. Melting point 148-150℃ (decomposition) NMR (CDCl 3 ) 7.73 (1H, d, J = 8.8Hz) 7.41 (2H, d, J = 8.3Hz) 7.35 (1H, d, J = 8.9Hz) 7.26 (2H, d, J=8.3Hz) 6.00 (1H, s) 5.57 (2H, s) 3.96 (3H, s) 2.41 (3H, s) 2.18 (3H, s) Examples 27 and 28 Follow the steps below in the same manner as Example 26. Each compound shown in Table 3 is obtained. Note that the compound of Example 26 is also listed in Table 3.
Claims (1)
として水酸基を有することのある低級アルキル
基、低級アルコキシカルボニル低級アルキル基、
低級アルキルカルボニルオキシ低級アルキル基、
低級アルコキシカルボニルオキシ低級アルキル
基、カルボキシ低級アルキル基又はベンゾイルオ
キシ低級アルキル基を示す。R3はアルキル基、
ヒドロキシ低級アルキル基、置換基として低級ア
ルキル基、ハロゲン原子、低級アルコキシ基、カ
ルボキシ基又はカルボキシ低級アルキル基を有す
ることのあるフエニル基、フエニル環上に置換基
として低級アルコキシ基を有することのあるフエ
ニル低級アルキル基、低級アルコキシカルボニル
低級アルキル基又はフラニル低級アルキル基を示
す。nは0、1又は2を示す〕 で表わされるナフトキノン誘導体及びその塩。[Claims] 1. General formula [In the formula, R 1 represents a lower alkyl group. R 2 is a lower alkyl group that may have a hydroxyl group as a substituent, a lower alkoxycarbonyl lower alkyl group,
lower alkylcarbonyloxy lower alkyl group,
Lower alkoxycarbonyloxy lower alkyl group, carboxy lower alkyl group or benzoyloxy lower alkyl group. R 3 is an alkyl group,
Hydroxy lower alkyl group, phenyl group that may have a lower alkyl group, halogen atom, lower alkoxy group, carboxy group, or carboxy lower alkyl group as a substituent, phenyl that may have a lower alkoxy group as a substituent on the phenyl ring It represents a lower alkyl group, a lower alkoxycarbonyl lower alkyl group, or a furanyl lower alkyl group. n represents 0, 1 or 2] A naphthoquinone derivative and a salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4512785A JPS61204162A (en) | 1985-03-06 | 1985-03-06 | Naphthoquinone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4512785A JPS61204162A (en) | 1985-03-06 | 1985-03-06 | Naphthoquinone derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61204162A JPS61204162A (en) | 1986-09-10 |
JPH0432060B2 true JPH0432060B2 (en) | 1992-05-28 |
Family
ID=12710601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4512785A Granted JPS61204162A (en) | 1985-03-06 | 1985-03-06 | Naphthoquinone derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61204162A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4849956B2 (en) * | 2006-05-22 | 2012-01-11 | 株式会社東海 | Igniter |
-
1985
- 1985-03-06 JP JP4512785A patent/JPS61204162A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61204162A (en) | 1986-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4425273A (en) | Process for production of chenodeoxycholic acid | |
AU574129B2 (en) | Arylacetic acid derivatives | |
HU201086B (en) | Diphenyl ether derivatives | |
EP0094102B1 (en) | 1-(1-cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation | |
US3925458A (en) | Process for preparing 2-(4-alkylphenyl)-propion-aldehyde and propionic acid | |
JPH0432060B2 (en) | ||
JPH0414091B2 (en) | ||
HU208533B (en) | Process for selective etherification of ascorbinic acid derivatives | |
JPH07215952A (en) | Catechol derivative | |
JPS629098B2 (en) | ||
JPH058691B2 (en) | ||
US4595767A (en) | 1,4-benzodioxine and 1,4-benzodioxine derivatives and production thereof | |
JPH0525078A (en) | Production of substituted acetoaldehyde | |
CH392483A (en) | Process for the preparation of new esters of 4-halo-3-sulfamoyl-benzoic acids | |
Tanaka | THE ACTION OF PERBENZOIC ACID ON GLUCAL AND ITS DERIVATIVES | |
US3027406A (en) | 3-hydroxy-3-biphenylylheptanoic acid | |
US3031481A (en) | 3-hydroxy-3-(nu-butyl)-7, 11-dimethyl-dodecanoic acid | |
JPH0129176B2 (en) | ||
JPS6126555B2 (en) | ||
KR950001277B1 (en) | Process for the preparation of oxybenzene derivatives | |
JPS6045613B2 (en) | Method for producing cis-3-hexene-1,6-diol | |
JPS597183A (en) | Naphthacenequinone derivative and its preparation | |
JPS6133138A (en) | Naphthoquinone derivative | |
JPS6141359B2 (en) | ||
JPS6361310B2 (en) |